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A 15-year-old Selle Francais gelding was presented to the equine referral hospital for 
treatment of a left guttural pouch mycosis previously diagnosed. After induction, the 
horse was shortly hoisted by all four feet, moved on a padded surgical table, and posi-
tioned in right lateral recumbency. In order to reduce the risk of bleeding during surgical 
manipulation of the carotid and maxillary arteries, a mean arterial pressure between 60 
and 70 mmHg was targeted. After surgery, the horse was moved in a padded recovery 
box keeping the same lateral recumbency. Four unsuccessful attempts were performed, 
with the horse always returning to sternal recumbency keeping the left hind limb up. 
At the fifth attempt, performed 120  min after the end of the general anesthesia, the 
horse stood up correctly but moderate ataxia and absence of weight bearing on the 
left hind limb were shown. Both the stifle and the fetlock joint were held in a flexed 
position and could not be extended properly in order to set the foot on the ground, 
resulting in a very short step. The horse was calm, not sweating, and willing to move; the 
muscles of the affected limb were relaxed, and the limb was neither warm nor painful at 
palpation. Occasionally, the horse flexed the affected hind limb in an exaggerated motion 
with marked abduction. No additional laboratory analyses were performed. Due to a 
strong suspicion of neuropathy, a sling support was initiated and a supportive bandage 
associated with flunixine administration was performed until resolution of the symptoms. 
The horse fully recovered after 3 days. This case report does not clarify the pathogenesis 
of the possible postanesthetic neuropathy accounted on the non-dependent limb, high-
lighting the need for future research in this field. Non-dependent limb neuropathy should 
be an expected problem even after having ruled out the most commonly known causes 
predisposing to postanesthetic lameness.
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INtRoDUCtIoN
The present case reports the suspicion of postanesthetic femoral paralysis of the non-dependent 
limb in a horse, an unexpected occurrence, which may induce serious complications.
A 15-year-old Selle Français gelding, with a weight of 570 kg and a body condition score of 4/5 
(1) was presented to the equine referral hospital for treatment of a left guttural pouch mycosis. 
Owner consent for publication of patient’s data was obtained. The infection did not affect any arterial 
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vessel and no bleeding had been reported by the owner or the 
private veterinarian. Surgery for arterial coil embolization was 
scheduled (2). Preanesthetic clinical examination revealed a heart 
rate (HR) of 28 beats/min, a respiratory rate (RR) of 16 breaths/
min, a rectal temperature of 37.3°C, and pink mucous membrane 
with a capillary refill time of 1.5 s. No abnormalities were detected 
on thorax auscultation and hematology and biochemistry were 
unremarkable. The horse had been treated for 2 days with local 
clotrimazol. Therefore, the patient was classified as an American 
Society of Anesthesiologist 2 category.
General anesthesia-related risks were considered and par-
ticular attention was placed on blood pressure management, 
with an aim to maintain a mean arterial blood pressure (MAP) 
between 60 and 70 mmHg in order to reduce the risk of bleed-
ing during surgical manipulation of the carotid and maxillary 
arteries.
As the animal was calm, a 14-G catheter was placed without 
sedation in the left jugular vein. Acepromazine (Prequillan, 
Boehringer Ingelheim GmbH, Switzerland) (0.02 mg kg−1) was 
administered intravenously (IV) 30 min before anesthesia induc-
tion. The horse was then moved into a padded induction box where 
xylazine (Xylasol, Graeub AG, Switzerland) (0.6  mg kg−1) and, 
immediately after, levomethadone (l-Polamivet, MSD Animal 
Health GmbH, Switzerland) (0.05  mg kg−1) were administered 
IV. Marked sedation was achieved within 10  min. Anesthesia 
was induced in a swing gate with diazepam (Valium, Roche 
Pharma, Switzerland) (0.05 mg kg−1) IV and ketamine (Ketasol, 
Graeub AG, Switzerland) (1.5 mg kg−1) IV (mixed in the same 
syringe), and, after flushing the catheter with saline, thiopental 
(Thiopental Inresa, Ospedalia AG, Switzerland) (1.5  mg kg−1) 
IV. The trachea was intubated with a 28 mm internal diameter 
endotracheal tube. The horse was shortly hoisted by all four feet 
and positioned in right lateral recumbency onto a padded surgical 
table. Both hind limbs were positioned parallel to the ground on 
a specific padded support, with the coxofemoral joint positioned 
in its spontaneous natural angle. Anesthesia was maintained with 
isoflurane in oxygen-enriched medical air [fraction of inspired 
oxygen (FiO2) = 55%] via a circle rebreathing system using an 
equine anesthetic machine (SurgiVet, Smiths medical, USA). 
Intravenous fluid therapy consisted of lactated Ringer’s solution 
(5 ml kg−1 h−1). A constant rate infusion of lidocaine (lidocaine 
2%, Streuli Pharma AG, Switzerland) was administered IV 
(1.8 mg kg−1 h−1). Physiological variables [HR, RR, hemoglobin 
saturation by pulsoximeter, end-tidal partial pressure of carbon 
dioxide (ETCO2), and invasive blood pressure] as well as FiO2 
and end-tidal percentage of isoflurane were monitored con-
tinuously using a multiparameter monitor (Datex-Ohmeda S/5, 
Datex-Ohmeda, Finland) and recorded manually every 5  min. 
A 20G arterial cannula was placed in the lateral metatarsal artery 
of the non-dependent limb (left). The transducer was zeroed to 
atmospheric pressure, positioned at the level of the heart, and a 
fast flush test confirmed normal damping of the system by visual 
observation.
Initial systolic (SAP), mean, and diastolic (DAP) arterial 
pressures measured approximately 30  min after anesthesia 
induction were 115, 74, and 87 mmHg, respectively. Isoflurane 
concentration was adjusted and a dobutamine IV infusion was 
prepared to be administered, if necessary. Although the horse 
maintained adequate ETCO2 in spontaneous ventilation, the 
breathing pattern was very irregular, and intermittent positive 
pressure ventilation was initiated 30 min after induction of anes-
thesia (tidal volume of approximately 6  l, RR of 7 breaths/min, 
peak inspiratory pressure of 12–15 cmH2O). At 1 and 2 h after 
induction of anesthesia, arterial blood was taken for gas analysis, 
revealing acceptable values (pH 7.36 and 7.33; partial pressure of 
carbon dioxide 58 and 60 mmHg, partial pressure of oxygen 134 
and 130  mmHg; lactate 1.1 and 1.0  mmol  l−1). The SAP, MAP, 
and DAP were maintained during the whole procedure between 
82 and 98  mmHg, 62 and 70  mmHg, and 41 and 63  mmHg, 
respectively, without the assistance of dobutamine. General 
anesthesia and surgical procedure were uneventful, and lasted 
190 and 145 min, respectively. Lidocaine infusion was stopped 
30 min before termination of anesthesia.
The horse was again shortly hoisted by all four feet, moved to 
the padded recovery box, and positioned in right lateral recum-
bency. Romifidine (Sedivet, Boehringer Ingelheim, Switzerland) 
(0.02  mg kg−1) was administered in the recovery box through 
the venous catheter and the horse was left to recover unassisted. 
The horse swallowed 20 min after end of anesthesia (EA) and the 
trachea was extubated. Xylazine (0.1 mg kg−1) was administered 
IV twice at 10 and 15 min after EA because of marked nystagmus. 
A first unsuccessful attempt to stand was made 40 min after EA, 
followed by three further unsuccessful attempts. Each attempt 
was quiet and no injuries were suspected. The horse always 
returned to sternal recumbency, with the left leg always remain-
ing the non-dependent one. It then stood up correctly on the fifth 
attempt, 120 min after EA. A recovery score of 2/5 [from 1 (best 
recovery possible) to 5 (worst recovery possible)] was attributed 
[following classification from Ref. (3)]. When standing, the horse 
showed moderate ataxia and absence of weight bearing on the 
left hind limb. Both the stifle and the fetlock joint were held in a 
flexed position and could not be extended properly in order to set 
the foot on the ground, resulting in a very short step. The horse 
was calm, willing to move, and not sweating; the muscles of the 
affected limb were relaxed, and the limb was neither warm nor 
painful on palpation. Occasionally, the horse flexed the affected 
hind limb in an exaggerated motion with marked abduction. 
No additional laboratory analyses were performed. As a result 
of the strong suspicion of neuropathy, a supportive bandage was 
applied to the left hind limb and the horse was provided sling 
support. Additionally, flunixine meglumine (Fluniximin, Graeub 
AG, Switzerland) (1.1 mg kg−1) IV was administered every 12 h, 
as well as thiamine (1.6 mg kg−1) and pyridoxine (0.7 mg kg−1) 
IV every 24  h (Corébral, Vetoquinol AG, Switzerland). As the 
horse was judged able to stand without distress, the sling support 
was removed on the same evening. Weight bearing progressively 
improved on the following day without further complication, 
and complete resolution of lameness was observed the third 
postoperative day.
BaCKGRoUND
Mortality associated with equine anesthesia has been reported 
to occur in 0.8–1.8% of elective surgeries, with values rising to 
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19.5% in emergency cases despite improvements in anesthetic 
techniques and physiological monitoring (4). The largest mortal-
ity studies conducted to date in horse, the Confidential Enquiry 
into Perioperative Equine Fatalities 1 and 2 (5), reported that 
fractures and myopathy were responsible for 32% of postopera-
tive mortality in non-colic surgeries. Myopathy may also occur 
alongside neuropathy, influencing the outcome and potentially 
increasing the risk of long bone fractures (4). Despite lack of 
pathognomonic symptoms, myopathy may be discriminated 
from neuropathy by presence of muscle stiffness and pain, leading 
eventually to fasciculation, sweating, and anxiety (6–8). Increased 
serum muscular enzymes and myoglobin, electromyography, 
ultrasonography, and nerve/muscular biopsy have been used 
to distinguish between the two conditions (6, 9–11), although 
clear differentiation between them can be challenging (8). 
Postanesthetic myopathy/neuropathy has been mostly reported 
in the dependent limbs. However, non-dependent forelimb neu-
ropathy (12) and suspicion of bilateral femoral neuropathy have 
been reported (11). The occurrence of postanesthetic myopathy/
neuropathy has been hypothesized to be caused by decreased tis-
sue perfusion and oxygenation (8, 9, 12). The principal causes for 
their development are arterial hypotension, poor surgical table 
padding, and inappropriate positioning leading to regional blood 
flow disturbances, local compression, and mechanical tension on 
the nerves.
Recommendations have been made to avoid postanesthetic 
myopathy/neuropathy development (8, 9, 13). The horse must 
be placed on the operating table in a position that does not 
put any part of its body under strain; regional venous outflow 
should be allowed and pressure increase within muscle bel-
lies avoided. Limbs should be allowed to settle naturally and 
be secured without force. When the horse is lying in lateral 
recumbency, both non-dependent limbs should be supported 
parallel to the ground, and the dependent forelimb should be 
pulled forward to reduce pressure on it from the chest. If access 
to the medial side of the dependent forelimb is required, the 
upper forelimb can be flexed. When the horse is lying in dorsal 
recumbency, care should be taken if leg extension locking the 
patellae is required and procedures longer than 20 min should 
be avoided in this position. Padding helps to spread the weight 
of the horse over a larger area of the body and should be deep 
enough to prevent the body reaching the table. Finally, a MAP 
>70 mmHg has been recommended to ensure a good muscular 
perfusion, decreasing the incidence of postanesthetic myopathy 
(14). Same recommendations apply to the recovery phase but, 
for practical reasons, the legs generally lie on the floor without 
support.
DIsCUssIoN
Report of neuropathy of the non-dependent hind limb, like in the 
present case, has not been reported yet to the authors’ knowledge.
Differentiation between myopathy and neuropathy can be 
challenging. They share common causes like arterial hypotension, 
poor padding of the surgical table, and inappropriate patient 
positioning, potentially leading to decreased tissue perfusion and 
oxygenation. Moreover, neuropathy and myopathy may occur in 
parallel. However, myopathy is generally associated with muscle 
stiffness, pain at palpation, sweating, and anxiety. In the present 
case, absence of these clinical signs led us to exclude a component 
of myopathy. Nerve compression and stretching with consequent 
nerve ischemia and hypoxia were suspected to be the most prob-
able mechanism behind the observed dysfunction.
As the affected limb was the non-dependent one, factors such 
as the table padding and horse positioning, which were standard 
in the present case (8), were unlikely to be the causes of the prob-
lem. Hoisting by all four limbs could have potentially induced 
nerve stretching leading to neuropraxia, although to the author’s 
knowledge, this has never been reported. The coxofemoral joint 
was positioned in its natural resting position, which should not 
lead to nerve damage.
Hypotension could have been a predisposing factor for the 
development of neuropathy. Because the non-dependent limb 
was elevated over the heart level, a decreased hydrostatic pres-
sure could have led to a reduction of muscle perfusion. However, 
in the present case, the arterial line was placed in the affected 
limb, and the MAP was maintained between 62 and 72 mmHg 
during the whole procedure, the lowest value being recorded 
during coil embolization. Therefore, intraoperative hypotension 
was unlikely to be the main cause of the postoperative complica-
tion. Since the arterial catheter was placed in the affected limb, 
good correlation between measured invasive blood pressure 
values and actual limb blood flow was expected. Dobutamine 
administration could have helped increasing femoral blood flow 
and possibly nerves perfusion (15–17). However, in equines, its 
effect on peripheral perfusion and microcirculation is still not 
well characterized (17–19).
In the present case, IV lidocaine was administered since the 
beginning of the surgical procedure. If ischemia was involved 
in the subsequent nerve dysfunction, its administration may 
have shortened normalization of the clinical condition; indeed, 
lidocaine has been shown to reduce reperfusion injury (20, 21).
The risk of developing postanesthetic myopathy/neuropathy 
increases with anesthesia duration (4). In the present case, the 
anesthesia lasted 190 min, which could have contributed to the 
development of neuropathy. The horse required further 120 min 
to stand up after EA. However, the first attempt was made 40 min 
after EA, and the underlying femoral paralysis leading to ataxia 
may have made it difficult for the horse to reach a stable standing 
position. Development of the neuropathy during recovery seems 
unlikely since the unsuccessful attempts were all quiet and the 
horse always returned to sternal recumbency keeping the left 
hind limb as the non-dependent.
In the present case, the clinical presentation suggested a 
femoral paralysis, while myopathy was considered rather unlikely 
because there was lack of pain, sweating, restlessness, muscular 
stiffness, fasciculation, and anxiety when the horse recovered 
from anesthesia. However, further analyses could have been help-
ful in the diagnostic process. Unexpectedly, high plasma creatine 
kinase values within a few hours after surgery may support a 
diagnosis of myopathy (8). Nevertheless, the same enzyme may 
be elevated with other causes of postanesthetic lameness such as 
peripheral neuropathy, because of secondary muscle damage, or 
a mixed myopathy–neuropathy (9). Aspartate aminotransferase 
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and myoglobin can also be elevated in cases of myopathy, with 
the latter leading to dark red or red/brown urine production 
(9). Hypoechoic areas within the muscle, when observed by 
ultrasonography, suggest muscle fiber disruption and acute injury 
(22) but the prognostic value of such observation is uncertain 
(6). Finally, muscle and nerve biopsy (11) and electromyography 
(10, 23) may distinguish between myopathy and neuropathy. 
However, in absence of local muscular symptoms, identifying a 
correct location to take the biopsy may be challenging. Moreover, 
changes associated with denervation are usually detectable by 
electromyography only 4–5  days after denervation (24, 25). 
Because of the strong suspicion of neuropathy, the fast improve-
ment of the clinical condition and the low reliability of possible 
further investigations, no supplementary tests were conducted.
Different treatments have been described for postanesthetic 
myopathy/neuropathy (6, 8, 9, 11, 12), but no clear guidelines 
have been established so far. In case of neuropathy symptomatic 
treatment with nonsteroidal anti-inflammatory agents, corticos-
teroids and dimethyl sulfoxide have been suggested to reduce 
neural edema. If the horse is able to stand, a supportive bandage 
and sling support could be applied. If needed, sedation and/or 
analgesia must be provided. In case a concomitant myopathy 
cannot be excluded, further treatment can be used. Dantrolene 
sodium has been described to relax muscles in cases with severe 
muscle stiffness. Fluid therapy should be initiated to prevent kid-
ney dysfunction because of myoglobinurea. Acepromazine may 
also improve lamellar blood flow, and anticoagulants (heparin, 
aspirin) have been suggested to prevent platelet aggregation and 
subsequent laminitis syndrome. Additionally, physiotherapy, 
massage, and ultraviolet light can be considered. In the present 
case, no signs of discomfort were shown by the animal and 
intense supportive therapy was not required.
CoNCLUDING ReMaRKs
We report a strong suspicion of postanesthetic femoral paralysis 
of the non-dependent limb. This case report does not clarify 
the possible pathogenesis of the suspected nondependent limb 
postanesthetic neuropathy, highlighting the need for future 
research in this field. Adequate padding, prudent positioning, 
and good perfusion pressure must be always considered impor-
tant factors for avoiding postanesthetic myopathy/neuropathy 
in horses.
aUtHoR CoNtRIBUtIoNs
AM, MK, and OL were involved in the care of the patient and 
were involved in planning this case report. AM was responsible 
for the conception of this case report and preparation of the first 
draft. MK and OL provided feedback and were involved in revis-
ing the manuscript. All the authors have read and approved the 
final version of the manuscript.
ReFeReNCes
1. Carrol CL, Huntington PJ. Body condition scoring and weight estimation 
of horses. Equine Vet J (1988) 20(1):41–5. doi:10.1111/j.2042-3306.1988.
tb01451.x 
2. Léveillé R, Hardy J, Robertson JT, Willis AM, Beard WL, Weisbrode SE, 
et  al. Transarterial coil embolization of the internal and external carotid 
and maxillary arteries for prevention of hemorrhage from guttural pouch 
mycosis in horses. Vet Surg (2000) 29(5):389–97. doi:10.1053/jvet.2000.7537 
3. Young SS, Taylor PM. Factors influencing the outcome of equine anaesthesia: 
a review of 1,314 cases. Equine Vet J (1993) 25(2):147–51. doi:10.1111/j. 
2042-3306.1993.tb02926.x 
4. Dugdale AH, Taylor PM. Equine anaesthesia-associated mortality: where are 
we now? Vet Anaesth Analg (2016) 43:242–55. doi:10.1111/vaa.12372 
5. Johnston GM, Eastment JK, Wood JLN, Taylor PM. The confidential enquiry 
into perioperative equine fatalities (CEPEF): mortality results of phases 
1 and 2. Vet Anaesth Analg (2002) 29:159–70. doi:10.1046/j.1467-2995. 
2002.00106.x 
6. Webb JK, van Loon JPAM. The Incidence of Post Anaesthetic Myopathy (PAM) 
in Horses after General Anaesthesia for MTI in Comparison to the Incidence of 
PAM in Horses Anaesthetised for Other Reasons. Utrecht: University of Utrecht, 
Faculty of Veterinary Medicine (2013).
7. Auer JA, Stick JA. Equine Surgery, Chapter 21. 4th ed. Saint Louis: Elsevier 
Saunders (2012). p. 251–2.
8. Taylor PM, Clarke KW. Handbook of Equine Anaesthesia. Chapter 7. 
Philadelphia: Saunders Elsevier (2007). p. 137–52.
9. Young SS. Post anaesthetic myopathy. Equine Vet Educ (2005) 7:60–3. 
doi:10.1111/j.2042-3292.2005.tb01829.x 
10. Wijnberg ID, Back W, De Jong M, Zuidhof MC, Van Den Belt AJM, van 
der Kolk JH. The role of electromyography in clinical diagnosis of neuro-
muscular locomotor problems in the horse. Equine Vet J (2004) 36:718–22. 
doi:10.2746/0425164044848019 
11. Dyson S, Taylor P, Whitwell K. Femoral nerve paralysis after general 
anesthesia. Equine Vet J (1988) 20:376–80. doi:10.1111/j.2042-3306.1988.
tb01550.x 
12. Oosterlinck M, Schauvliege S, Martens A, Pille F. Postanesthetic neuropathy/
myopathy in the nondependent forelimb in 4 horses. J Equine Vet Sci (2013) 
33:996–9. doi:10.1016/j.jevs.2013.03.181 
13. Duke T, Filzek U, Read MR, Read EK, Ferguson JG. Clinical observations 
surrounding an increased incidence of postanesthetic myopathy in halothane- 
anesthetized horses. Vet Anaesth Analg (2006) 33:122–7. doi:10.1111/j.1467- 
2995.2005.00189.x 
14. Schauvliege S, Gasthuys F. Drugs for cardiovascular support in anesthetized 
horses. Vet Clin North Am Equine Pract (2013) 29(1):19–49. doi:10.1016/j.
cveq.2012.11.011 
15. Schier MF, Raisis AL, Secombe CJ, Hosgood G, Musk GC, Lester GD. Effects 
of dobutamine hydrochloride on cardiovascular function in horses anesthe-
tized with isoflurane with or without acepromazine maleate premedication. 
Am J Vet Res (2016) 77:1318–24. doi:10.2460/ajvr.77.12.1318 
16. Wang Y, Tang P, Zhang L, Guo Y, Wan W. Quantitative evaluation of the 
peripheral nerve blood perfusion with high frequency contrast-enhanced 
ultrasound. Acad Radiol (2010) 17:1492–7. doi:10.1016/j.acra.2010. 
07.007 
17. Raisis AL, Young LE, Blissitt KJ, Walsh K, Meire HB, Taylor PM, et al. Effect 
of a 30-minute infusion of dobutamine hydrochloride on hind limb blood 
flow and hemodynamics in halothane-anesthetized horses. Am J Vet Res 
(2000) 61:1282–8. doi:10.2460/ajvr.2000.61.1282 
18. Dancker C, Hopster K, Rohn K, Kästner SB. Effects of dobutamine, dopamine, 
phenylephrine and noradrenaline on systemic haemodynamics and intestinal 
perfusion in isoflurane anaesthetised horses. Equine Vet J (2018) 50:104–10. 
doi:10.1111/evj.12721 
19. Loughran CM, Raisis AL, Hosgood G, Secombe CJ, Lester GD. The effect of 
dobutamine and bolus crystalloid fluids on the cardiovascular function of 
isoflurane-anaesthetised horses. Equine Vet J (2017) 494:369–74. doi:10.1111/
evj.12605 
20. Lan W, Harmon D, Wang JH, Ghori K, Shorten G, Redmond P. The effect 
of lidocaine on in  vitro neutrophil and endothelial adhesion molecule 
expression induced by plasma obtained during tourniquet-induced isch-
aemia and reperfusion. Eur J Anaesthesiol (2004) 21:892–7. doi:10.1017/
S0265021504000249 
5Mirra et al. Equine Postanesthetic Femoral Paralysis
Frontiers in Veterinary Science | www.frontiersin.org February 2018 | Volume 5 | Article 12
21. Cassutto BH, Gfeller RW. Use of intravenous lidocaine to prevent reperfusion 
injury and subsequent multiple organ dysfunction syndrome. J Vet Emerg 
Crit Care (2003) 13(3):137–48. doi:10.1046/j.1435-6935.2003.00080.x 
22. Valber SJ. Approach the horse with a suspected myopathy. World Equine 
Veterinary Association (WEVA), Proceedings of the 11th International Congress. 
Guarujá, SP, Brazil (2009).
23. Wijnberg ID, Franssen H. The potential and limitations of quantitative 
electromyography in equine medicine. Vet J (2016) 209:23–31. doi:10.1016/j.
tvjl.2015.07.024 
24. Cuddon PA. Electrophysiology in neuromuscular disease. Vet Clin North 
Am Small Anim Pract (2002) 32:31–62. doi:10.1016/s0195-5616(03)00079-2 
25. van Wessum R, Sloet van Oldruitenborgh-Oosterbaan MM, Clayton HM. 
Electromyography in the horse in veterinary medicine and in veterinary 
research—a review. Vet Q (1999) 21:3–7. doi:10.1080/01652176.1999. 
9694983 
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could be 
construed as a potential conflict of interest.
Copyright © 2018 Mirra, Klopfenstein Bregger and Levionnois. This is an open-access 
article distributed under the terms of the Creative Commons Attribution License 
(CC BY).The use, distribution or reproduction in other forums is permitted, provided 
the original author(s) and the copyright owner are credited and that the original 
publication in this journal is cited, in accordance with accepted academic practice. No 
use, distribution or reproduction is permitted which does not comply with these terms.
